Results 31 to 40 of about 254,908 (357)

Statins and cancers [PDF]

open access: yesWspółczesna Onkologia, 2015
Statins (inhibitors of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase) are a group of drugs used to treat lipid disorders. They inhibit cholesterol synthesis at an early stage of the biosynthesis pathway, thus eliminating numerous metabolites involved in the cycle.
Stryjkowska-Góra, Aleksandra   +3 more
openaire   +2 more sources

The pharmacological bases for repurposing statins in depression: a review of mechanistic studies

open access: yesTranslational Psychiatry, 2023
Statins are commonly prescribed medications widely investigated for their potential actions on the brain and mental health. Pre-clinical and clinical evidence suggests that statins may play a role in the treatment of depressive disorders, but only the ...
Riccardo De Giorgi   +5 more
doaj   +1 more source

Statin Hepatotoxicity: Is it a Real Concern?

open access: yesHeart Views, 2011
Statins are the most effective and widely used drugs for treating dyslipidemia, a major risk factor for coronary heart disease. These are one of the safest hypolipidemic drugs but many patients are advised to discontinue statins for the fear of ...
Pranav Sikka, K K Saxena, Seema Kapoor
doaj   +1 more source

Effect of statins on post-contrast acute kidney injury: a multicenter retrospective observational study

open access: yesLipids in Health and Disease, 2021
Background Post-contrast acute kidney injury (PC-AKI) is a severe complication of coronary angiography (CAG) and percutaneous coronary intervention (PCI). Currently, the effect of statins on PC-AKI and its mechanism remains unclear.
Maoning Lin   +8 more
doaj   +1 more source

Prospects for the use of statins in antiviral therapy [PDF]

open access: yesКлиническая микробиология и антимикробная химиотерапия, 2023
Inhibitors of hydroxymethylglutaryl-CoA reductase, in addition to suppressing cholesterol synthesis, have an antiviral effect. Clinical studies have shown antiviral efficacy of statins against COVID-19, HCV, HBV, RSV, HIV, influenza viruses.
Mustafin R.N.
doaj   +1 more source

Statins as Anticancer Agents in the Era of Precision Medicine

open access: yesClinical Cancer Research, 2020
Statins are widely prescribed cholesterol-lowering drugs that inhibit HMG-CoA reductase (HMGCR), the rate-limiting enzyme of the mevalonate metabolic pathway.
Joseph Longo   +4 more
semanticscholar   +1 more source

Pleiotropic effects of statins: a focus on cancer.

open access: yesBiochimica et Biophysica Acta - Molecular Basis of Disease, 2020
The statin drugs ('statins') potently inhibit hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase by competitively blocking the active site of the enzyme.
M. Ahmadi   +13 more
semanticscholar   +1 more source

Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins [PDF]

open access: yes, 2014
Statins effectively lower LDL cholesterol levels in large studies and the observed interindividual response variability may be partially explained by genetic variation.
Herrington, D.M.   +627 more
core   +2 more sources

Heterologous expression of MlcE in Saccharomyces cerevisiae provides resistance to natural and semi-synthetic statins

open access: yesMetabolic Engineering Communications, 2015
Statins are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase, the key enzyme in cholesterol biosynthesis. Their extensive use in treatment and prevention of cardiovascular diseases placed statins among the best selling drugs. Construction of
Ana Ley   +2 more
doaj   +1 more source

Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials [PDF]

open access: yes, 2012
Background - It has been suggested that statins substantially reduce the risk of venous thromboembolic events. We sought to test this hypothesis by performing a meta-analysis of both published and unpublished results from randomised trials of statins.
Jacquet Hervet, Michel   +134 more
core   +2 more sources

Home - About - Disclaimer - Privacy